GREENSBORO, N.C., Nov. 12, 2019 /PRNewswire/ -- Select MultiGen Diagnostics, LLC, an affiliated company of Select Laboratory Partners, Inc., located in Greensboro, NC, will participate in a research study conducted by  Teaching Hospital, Jaffna, and the Tellipalai Trail Cancer Hospital, Sri Lanka to investigate the p

IRVINE, Calif., Nov. 12, 2019 /PRNewswire/ -- Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced that it will be presenting new data supporting its methylation-based liver cancer diagnostic test at The Liver Meeting® 2019 hosted by the American Associ

SAN CARLOS, Calif., Nov. 12, 2019 /PRNewswire/ -- RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies to improve outcomes for cancer and serious autoimmune disease patients, today announced the appointment of Rakesh Verma, Ph.D., as the Company's Senior Vice President, Discovery &

HARRISBURG, Pa., Nov. 12, 2019 /PRNewswire/ -- Therap's billing system includes features for Pennsylvania providers supporting people with Intellectual and Developmental Disabilities (I/DD), enabling them to bill for both Community Participation Services (CPS) and residential services directly from documentation collected at the poin

WASHINGTON, Nov. 12, 2019 /PRNewswire/ -- Trio Health, a leading provider of real-world evidence, announced results from a study recently presented at the Annual Meeting of the American College of Rheumatology. ''The perception is that patients with rheumatoid arthritis, who also have comorbidities, have higher costs of their RA-related care compared to patients w

WATERBURY, Conn., Nov. 12, 2019 /PRNewswire/ -- Therap's disability software features multiple tools for health care support professionals to document services and track individual health data.  Its Medication Administration Recording (MAR) tool for tracking medications allows a health professional, certified or licensed staff to document medications administered. T

BOSTON, Nov. 12, 2019 /PRNewswire/ -- Pri-Med, a leader in continuing medical education, is pleased to announce a new partnership with the Sjögren's Syndrome Foundation (SSF), the only national nonprofit organization focused on increasing research, education, and awareness for Sjögren's. Together, Pri-Med and SSF will deliver "Sjögren's Syndrome: A Co

MARLBOROUGH, Mass., Nov. 12, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) (the "Company") completed a public offering of €900.0 million aggregate principal amount of 0.625% Senior Notes due 2027 (the "Notes").  The Company has applied to list the Notes on the New York Stock Exchange.

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the third q

STAINES-UPON-THAMES, United Kingdom, Nov. 12, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced data on patient